NLTX -19%/PM on FDA clinical hold of IND: http://www.globenewswire.com/news-release/2021/01/08/2155540/0/en/Neoleukin-Therapeutics-Receives-Clinical-Hold-Letter-from-U-S-FDA-Related-to-CMC-Assay-Development-for-NL-201.html